Skip to main content
. 2018 Jul 11;16(3):3674–3680. doi: 10.3892/ol.2018.9127

Table III.

Characteristics of cetuximab retreatment.

Treatment characteristics n
Therapeutic line of cetuximab retreatment
  3 6
  4 1
  5 2
  6 5
Adjunct chemotherapy regimen
  CPT-11 14
Median interval time between prior and cetuximab retreatment, months (range) 13.1 (6.0–37.1)

CPT-11, irinotecan.